TTR and early-onset autosomal dominant Alzheimer disease: Ttr (transthyretin) has been shown to prevent amyloid formation and is thought to have a protective role [47, 48], but the increased expression of Ttr in this sample could not be confirmed in other Alzheimer’s disease model samples of the same study.